eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2008
vol. 25
 
Share:
Share:
abstract:

CASE REPORTS
Sweet’s syndrome in Kostmann disease – association with pegfilgrastim

Anna Lis-Święty
,
Ligia Brzeźińska-Wcisło
,
Sławomira Kyrcz-Krzemień
,
Iwona Rogala-Poborska

Post Dermatol Alergol 2008; XXV, 3: 135–137
Online publish date: 2008/07/09
View full text Get citation
 
Sweet’s syndrome is characterized by erythematous-oedematous lesions with neutrophilic infiltrate in the upper part of the dermis, often accompanied by fever and increased count of neutrophils in the peripheral blood. The forms induced by various medications: all-trans retinoic acid, carbamazepine, hydralazine, levonorgestrel/ethinyl estradiol, minocycline, trimethoprim/sulfamethoxazole and granulocyte colony-stimulating factor (G-CSF). A case of pegfilgrastim-induced (recombinant human G-CSF) Sweet’s syndrome in a 23-year-old woman with severe congenital neutropenia (SCN) (Kostmann disease) is presented. Thus far reports of G-CSF-induced Sweet’s syndrome have been related to patients treated because of complications in the course of haematological malignancies.
keywords:

Sweet’s syndrome, granulocyte colony-stimulating factor, Kostmann disease

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.